H2 Hydrogen Bottle – Family Pack 3+1 Free

An interview on Czech Radio at 6:20 a.m. with neurologist Prof. MUDr. David Školoudík, Ph.D., FESO, FEAN, and David Maršálek, CEO and Founder of H2 Global Group, discussing molecular hydrogen and the first clinical study of its kind in the Czech Republic.

An interview on Czech Radio at 6:20 a.m. with neurologist Prof. MUDr. David Školoudík, Ph.D., FESO, FEAN, and David Maršálek, CEO and Founder of H2 Global Group, discussing molecular hydrogen and the first clinical study of its kind in the Czech Republic.

H2 Medical Technologies is issuing a public call for volunteers who wish to participate in the study and meet the basic criteria:

  • age 50–80 years,

  • overall good health,

  • a diagnosis of mild cognitive impairment (MCI) or mild to moderate dementia,

  • preferably residence in Ostrava or the surrounding area, where the study will be conducted.

Participation in the study does not guarantee any health benefit and should not be considered a substitute for standard treatment. Interested individuals may apply by January 19, 2026, by email at:
📧 david.skoloudik@H2medical.com

You can find the interview and the full article here:
🔗 https://www.irozhlas.cz/zivotni-styl/zdravi/v-ostrave-se-chysta-unikatni-klinicka-studie-overi-jak-muze-vdechovani-vodiku_2512151057_ntu